A 340B Navigation Guide for Pharmaceutical ManufacturersByKyle ForcierSeptember 12th 2023How drugmakers can navigate the program’s pricing challenges and regulatory developments.
The potential for outcomes-based contractingByKyle ForcierOctober 30th 2014Contracts with payers that contain terms based on outcomes can highlight a drug's value